These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7829577)

  • 21. Caveolin-1 binding motif of alpha-hemolysin: its role in stability and pore formation.
    Pany S; Vijayvargia R; Krishnasastry MV
    Biochem Biophys Res Commun; 2004 Sep; 322(1):29-36. PubMed ID: 15313169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.
    Joubert O; Viero G; Keller D; Martinez E; Colin DA; Monteil H; Mourey L; Dalla Serra M; Prévost G
    Biochem J; 2006 Jun; 396(2):381-9. PubMed ID: 16494579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroosmotic enhancement of the binding of a neutral molecule to a transmembrane pore.
    Gu LQ; Cheley S; Bayley H
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15498-503. PubMed ID: 14676320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stochastic sensing of organic analytes by a pore-forming protein containing a molecular adapter.
    Gu LQ; Braha O; Conlan S; Cheley S; Bayley H
    Nature; 1999 Apr; 398(6729):686-90. PubMed ID: 10227291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus bicomponent gamma-hemolysins, HlgA, HlgB, and HlgC, can form mixed pores containing all components.
    Dalla Serra M; Coraiola M; Viero G; Comai M; Potrich C; Ferreras M; Baba-Moussa L; Colin DA; Menestrina G; Bhakdi S; Prévost G
    J Chem Inf Model; 2005; 45(6):1539-45. PubMed ID: 16309251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular architecture of a toxin pore: a 15-residue sequence lines the transmembrane channel of staphylococcal alpha-toxin.
    Valeva A; Weisser A; Walker B; Kehoe M; Bayley H; Bhakdi S; Palmer M
    EMBO J; 1996 Apr; 15(8):1857-64. PubMed ID: 8617232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The internal cavity of the staphylococcal alpha-hemolysin pore accommodates approximately 175 exogenous amino acid residues.
    Jung Y; Cheley S; Braha O; Bayley H
    Biochemistry; 2005 Jun; 44(25):8919-29. PubMed ID: 15966717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative assembly of beta-barrel pore-forming toxins.
    Nguyen VT; Kamio Y
    J Biochem; 2004 Nov; 136(5):563-7. PubMed ID: 15632294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The staphylococcal alpha-toxin pore has a flexible conformation.
    Vécsey-Semjén B; Knapp S; Möllby R; van der Goot FG
    Biochemistry; 1999 Apr; 38(14):4296-302. PubMed ID: 10194347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrogating single proteins through nanopores: challenges and opportunities.
    Movileanu L
    Trends Biotechnol; 2009 Jun; 27(6):333-41. PubMed ID: 19394097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designed protein pores as components for biosensors.
    Braha O; Walker B; Cheley S; Kasianowicz JJ; Song L; Gouaux JE; Bayley H
    Chem Biol; 1997 Jul; 4(7):497-505. PubMed ID: 9263637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pore-forming protein with a protease-activated trigger.
    Walker B; Bayley H
    Protein Eng; 1994 Jan; 7(1):91-7. PubMed ID: 8140099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Building doors into cells.
    Bayley H
    Sci Am; 1997 Sep; 277(3):62-7. PubMed ID: 9274040
    [No Abstract]   [Full Text] [Related]  

  • 35. Switching a bacterial toxin to good use.
    Travis J
    Science; 1993 Dec; 262(5140):1646. PubMed ID: 8259508
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversal of charge selectivity in transmembrane protein pores by using noncovalent molecular adapters.
    Gu LQ; Dalla Serra M; Vincent JB; Vigh G; Cheley S; Braha O; Bayley H
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3959-64. PubMed ID: 10760267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular insight into the inhibition mechanism of cyrtominetin to α-hemolysin by molecular dynamics simulation.
    Niu X; Qiu J; Wang X; Gao X; Dong J; Wang J; Li H; Zhang Y; Dai X; Lu C; Deng X
    Eur J Med Chem; 2013 Apr; 62():320-8. PubMed ID: 23376250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pore-forming proteins and their application in biotechnology.
    Panchal RG; Smart ML; Bowser DN; Williams DA; Petrou S
    Curr Pharm Biotechnol; 2002 Jun; 3(2):99-115. PubMed ID: 12022262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery.
    Yang NJ; Liu DV; Sklaviadis D; Gui DY; Vander Heiden MG; Wittrup KD
    Mol Pharm; 2015 Jun; 12(6):1992-2000. PubMed ID: 25881713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research on the hemolytic activity of staphylococcal alpha-hemolysin].
    ORSI N; POGGIOLINI D
    Riv Biol; 1962; 55():361-73. PubMed ID: 13940408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.